Iain Peter Fraser

Title: Iain Peter Fraser: Innovator in Pain Management

Introduction

Iain Peter Fraser is a notable inventor based in Scotch Plains, NJ (US). He has made significant contributions to the field of pain management through his innovative approaches and patented methods. With a total of 3 patents, Fraser's work focuses on treating inflammation and neuropathic pain.

Latest Patents

Fraser's latest patents include groundbreaking methods for treating inflammation or neuropathic pain. These methods utilize an effective dose of a monoacylglycerol lipase inhibitor or a composition thereof. Another significant patent involves the development of radiolabeled monoacylglycerol lipase occupancy probes. These probes comprise a monoacylglycerol lipase (MGLL) inhibitor containing a positron emission tomography (PET) tracer radionuclide. Additionally, he has outlined methods for assessing MGLL enzyme occupancy of a MGLL inhibitor using the described radiolabeled occupancy probes.

Career Highlights

Throughout his career, Iain Peter Fraser has worked with esteemed organizations such as Lundbeck La Jolla Research Center, Inc. and H. Lundbeck A/S. His experience in these companies has allowed him to refine his expertise in the field of pain management and drug development.

Collaborations

Fraser has collaborated with notable colleagues, including Cheryl A. Grice and Todd Kevin Jones. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Iain Peter Fraser's innovative work in pain management has led to significant advancements in the treatment of inflammation and neuropathic pain. His contributions through patents and collaborations highlight his commitment to improving healthcare solutions.